Care Access Research - Scranton — Scranton, Pennsylvania

Care Access Research - Scranton is a clinical research site located in Scranton, Pennsylvania, United States 18508.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Care Access Research - Scranton has participated in 1 clinical trials.

Therapeutic areas: Crohn's Disease.

Sponsors: Eli Lilly and Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Scranton

Browse all research sites in Pennsylvania · View every site in Scranton

• Mercy Hospital Cancer Center - Scranton
• Regional Hospital of Scranton
• Moses Taylor Hospital
• Mercy Hospital
• Marywood University
• Community Medical Center
• Scranton Hematology Oncology
• Hematology and Oncology Associates of North East Pennsylvania
• Hematology and Oncology Associates of Northeastern Pennsylvania
• Research Site
• Hematology and Oncology Associates
• Northeast Clinical Trials Group

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Care Access Research - Scranton?

Care Access Research - Scranton has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Care Access Research - Scranton conducted?

Care Access Research - Scranton has 1 clinical trials on record. Their work covers Crohn's Disease.

Is Care Access Research - Scranton accredited by Crixeo Clinical Trials?

Care Access Research - Scranton has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Care Access Research - Scranton?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.